Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Sponsor: Ascidian Therapeutics, Inc
Summary
This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.
Official title: Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials
Key Details
Gender
All
Age Range
5 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2024-06-20
Completion Date
2030-08-31
Last Updated
2026-03-11
Healthy Volunteers
No
Interventions
Prescreening Assessments
Various genetic and visual assessments.
Locations (8)
University of San Francisco
San Francisco, California, United States
Vitreo Retinal Associates
Gainesville, Florida, United States
Wilmer Eye Institute at John Hopkins
Baltimore, Maryland, United States
Massachusetts Eye and Ear
Boston, Massachusetts, United States
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan, United States
Cincinnati Eye Institute
Cincinnati, Ohio, United States
Retina Foundation of Texas
Dallas, Texas, United States
Retina Consultants of Texas
Houston, Texas, United States